10 studies found for:    pr610
Show Display Options
Rank Status Study
1 Terminated A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: PR610
2 Completed
Has Results
Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease
Conditions: Parkinson Disease;   Parkinson's Disease
Interventions: Drug: ropinirole PR/XR;   Drug: ropinirole IR
3 Completed
Has Results
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
Condition: Bipolar Disorder
Interventions: Drug: Lithium or Valproate with placebo (PBO);   Drug: Lithium or Valproate with Aripiprazole
4 Terminated A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
Conditions: Colorectal Cancer;   Steatohepatitis
Intervention: Drug: Metformin/Placebo
5 Completed A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: placebo;   Drug: taspoglutide
6 Active, not recruiting Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention:
7 Completed A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Platinum-based chemotherapy;   Drug: bevacizumab [Avastin]
8 Completed A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: erlotinib [Tarceva];   Drug: fusidic acid [Verutex];   Drug: erythromycin [Eritex];   Drug: Fisiogel
9 Recruiting A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Drug: bevacizumab [Avastin];   Drug: carboplatin
10 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study Comparing CroFab® Versus Placebo With Rescue Treatment for Copperhead Snake Envenomation
Condition: Agkistrodon Contortrix Envenomation
Interventions: Biological: crotilidae polyvalent immune fab (ovine);   Biological: Placebo

Indicates status has not been verified in more than two years